MNQ 0.00% 0.0¢ minquest limited

Nice to see we are back again. Good be really good MT-LT...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,245 Posts.
    lightbulb Created with Sketch. 26
    Nice to see we are back again. Good be really good MT-LT investment and can follow same path as RAP & MDR.

    Cost effective Pain assessment tool - A point of care App which utilises facial recognition technology to detect micro- expressions which are indicative of presence of pain.

    ePAT App is designed to allow pain assessments to be: § Simple § Accurate § Objective § Reproducible

    Opportunistic markets where there is a current need for ePAT technology, examples include: § Tele-Health Ø Support clinician remote patient assessments § Insurance Claims Ø Assisting in assessment of personal injury claims § Pharmaceutical Companies Ø Monitoring tool for clinical trials of pain relief drugs.


    ePAT vs Abbey Pain Scale
    Patients n = 40
    Assessments = 354
    Correlation coefficient = 0.90

    Fund is raised for near 2 years est budget and NO CR expected anytime soon.
    [email protected] were issued to raise $4.5M
    Out of 657m ; 213m (34%) are escrowed for 2 years


    Taking its time but this could proven to be another RAP. Patience is the key for MT-LT.
 
watchlist Created with Sketch. Add MNQ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.